Metabolism of Pregnenolone and Pregnenolone Sulphate in Benign Essential Hypertension

Abstract
Patients with benign essential hypertension excreted in their urine less of the radioactive label associated with the injected tracer 3H-pregnenolone sulphate than control subjects, but more of the label associated with the 14C-pregnenolone tracer. In both groups, there was no difference in the urinary production rate of pregnenolone. Patients with benign essential hypertension had a higher production rate of pregnenolone sulphate. The 3H/14C ratio in the urinary metabolites pregnenediol glucuronide and sulphate were higher in control subjects. There was no difference in the excretion of pregnenediol, 17α-hydroxypregnenolone and pregnenetriol conjugates except for pregnenetriol sulphate which was found markedly lower in patients.